Shelley Forrest
The University of Sydney
Australia
Development of staging criteria to distinguish preclinical tauopathies from primary age-related tauopathy (PART)
Alzheimer's Australia Dementia Research Foundation
8,412
01/01/2015
1
The Rosemary Foundation Travel Fellowship will enable Dr Forrest to present her research at the 10th International Conference on Frontotemporal Dementias in Munich, 2016. She will also spend time in the laboratory of prominent neuropathologist, Associate Professor Kovacs at the Institute of Neurology, Medical University of Vienna. Associate Professor Kovacs is internationally recognised for his contributions in the neuropathology of normal aging, diseases characterised by the deposition of a protein called tau such as frontotemporal dementia and Alzheimers disease and other neurodegenerative diseases. He is a member of an international consortium that recently developed harmonised classification criteria for two novel tau-depositing pathologies. Both of these newly classified tau pathologies have implications for defining normal age-related changes in the brain, and tau-related mechanisms in frontotemporal dementia versus Alzheimers disease. Visiting the Kovacs laboratory will provide Dr Forrest with the opportunity to gain first hand experience in the identification and characterisation of these novel pathologies, and broaden her knowledge of better-established tau pathologies.
https://www.dementiaresearchfoundation.org.au/researchers/shelley-forrest